The Impact of Tralokinumab on Quality of Life and School in Patients Aged 12-17 With Atopic Dermatitis: Results from the Phase 3 ECZTRA 6 Trial. J of Skin 2023, 7 (2), s139. https://doi.org/10.25251/skin.7.supp.139.